We are live on ! Find out more
NRXPW

NRX Pharmaceuticals Warrant
NRXPW

Delisted

NRXPW was delisted on the 22nd of May, 2026.

Back to rankings

19 hedge funds and large institutions have $663K invested in NRX Pharmaceuticals Warrant in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 19 → 19 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

1% less capital invested

Capital invested by funds: $669K → $663K (-$6K)

Holders
19
Holders Change
–
Holders Change %
0%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KPF
K2 Principal Fund
Ontario, Canada
+$18.4K
2
Walleye Trading
Walleye Trading
New York
+$999
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$182
4
UBS Group
UBS Group
Switzerland
+$91

Top Sellers

Rank Fund Capital Flow
1
OAM
Oxford Asset Management
United Kingdom
-$21K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1
Boothbay Fund Management
New York
$362K – – –
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$65K – – –
VOAM
3
Vertex One Asset Management
British Columbia, Canada
$35K – – –
Hudson Bay Capital Management
4
Hudson Bay Capital Management
Connecticut
$30K – – –
VAS
5
VR Advisory Services
Cayman Islands
$28K – – –
RCM
6
Rivernorth Capital Management
Florida
$21K – – –
AA
7
AQR Arbitrage
Connecticut
$17K – – –
PC
8
Periscope Capital
Ontario, Canada
$16K – – –
KPF
9
K2 Principal Fund
Ontario, Canada
$16K +$18.4K +101,200 New
6CM
10
683 Capital Management
New York
$15K – – –
YCM
11
Yakira Capital Management
Connecticut
$15K – – –
BI
12
Bulldog Investors
New Jersey
$11K – – –
CAC
13
Cowen and Company
New York
$10K – – –
GCL
14
Glazer Capital LLC
New York
$10K – – –
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$5K +$182 +1,000 +3%
Walleye Trading
16
Walleye Trading
New York
$3K +$999 +5,500 +38%
LIM
17
Longfellow Investment Management
Massachusetts
$2K – – –
HIM
18
HGC Investment Management
Ontario, Canada
$1K – – –
UBS Group
19
UBS Group
Switzerland
$1K +$91 +500 +10%
OAM
20
Oxford Asset Management
United Kingdom
– -$21K -105,000 Closed

NRXPW Hedge Fund Activity: Q4 2019 in Review

19 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals Warrant (NRXPW) for Q4 2019, worth a combined $663K — down 0.9% from $669K a quarter earlier.

Fund positioning in NRXPW was balanced in Q4 2019: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 0 trimmed.

The largest buyer was K2 Principal Fund, opening a new position worth an estimated $18.4K. The largest seller was Oxford Asset Management, exiting entirely with an estimated $21K sold.

  • 19 institutional investors held NRX Pharmaceuticals Warrant (NRXPW) as of Q4 2019, unchanged from Q3 2019.
  • Funds reported $663K of NRX Pharmaceuticals Warrant stock for Q4 2019, down 0.9% quarter-over-quarter.
  • 1 fund opened new NRX Pharmaceuticals Warrant positions in Q4 2019 and 1 closed out, a net change of 0 holders.
  • The largest NRX Pharmaceuticals Warrant buyer in Q4 2019 was K2 Principal Fund, an estimated $18.4K added.
  • The largest NRX Pharmaceuticals Warrant seller in Q4 2019 was Oxford Asset Management, an estimated $21K sold.

Based on aggregated 13F filings for Q4 2019.